Platelet Refractoriness
Keywords:
-Abstract
-
Downloads
References
Dutcher JP, Schiffer CA, Aisner J, et al. Long-tem follow-up of patients with leukemia receiving platelet transfusions : identification of a large group of patients who do not become alloimmunization. Blood 1981;58:1007.
Bishop JF, McGrath K, Wolf MM, et al. Clinical factors influencing the efficacy of pooled platelet transfusion. Blood 1988;71:383.
Klumpp TR, Heman J, Innis S, et al. Factors associated with response to platelet transfusion following hematopoietic stem cell transplantation. Bone Marrow Transplant 1996;17:1035.
Doughty HA, Murphy MF, Metcalfe P, et al. Relative importance of immune and non-immune causes of platelet refractoriness. Vox Sang 1994;66:200.
Dutcher JP, Schiffer CA, Aisner J, et al. Alloimmunization following platelet transfusion: the absence of a dose-reponse relationship. Blood 1981;57:395.
Hogge DE, Dutcher JP, Aisner J, et al. Lymphocytotoxic antibody is a predictor of response to random donor platelet transplantation. Am J Hematol 1983;14:363.
Gelb AB, Leavitt AD. Crossmatch-compatible platelet improve corrected count increments in patitnets who are refractory to randomly selected platelets. Transfusion 1997;37:624.
Lee EJ, Schiffer CA. Serial measuremet of lymphocytotoxic antibody and response to nonmatched platelet transfusion in alloimmunized patient. Blood 1987;70:1727.
The Trial to Reduce Alloimmunization to Platelet Study Group: leukocyte reduction and ultraviolet B iradion of platelets to prevent allcimmunization and refractoriness to platelet transfusions. N Engl J Med 1997;337:1861.
Duquesnoy RJ, Filip DJ, Rodey GE, et al. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients. Am I Hematol 1977;22:219.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
